SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Nanoviricides - The Other Board -- Ignore unavailable to you. Want to Upgrade?


To: Its_lose_not_loose who wrote (708)5/23/2018 12:20:46 PM
From: arvitarRead Replies (1) | Respond to of 1010
 
There were so many things wrong with this company from the start. I think the old adage about not investing in what you don't know about is a good one. But only if correctly understood.

"Knowing about" in this case means having knowledge and experience about successfully developing drug candidates through a startup pharma. This is about understanding the FDA regulatory process and startup businesses. Knowing something about basic academic science is irrelevant, as proven by all the PhD's on IHUB who are repeat saps in these biowreck scams (SPAZ-md/65 might be one of those, in spite of her dumbness. There are as many really stoopid putzs with PhDs as there are genuinely brilliant people with PhDs).

Anyways, anyone who truly knows about successful drug development and startup pharma, would have known before day-1 with absolute certainty that NNVC was either a complete scam, or Seymour and Diwan were both delusional imbeciles who just accidentally set things up so one of them would transfer 30% of every dollar invested into his personal bank account.

There's a book I recently came across that I'd recommend to anyone wanting to learn about this stuff:

New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients, by Lawrence T. Friedhoff.

Here's a quote from the preface, that if anyone read and took seriously, would have known that NNVC was doomed from the start:

"Finally, I would like to give an important cautionary note: Drug development, particularly the development of a completely new drug, is an extremely complex and expensive undertaking. Each year thousands of companies try and almost all of the fail....most drug development professionals go their their entire career without ever seeing of of their products approved for marketing. Because the process is so challenging and the risks so high, drug development should ALWAYS be handled by the most competent and experienced personnel. So, don't try this at home without guidance from an experienced professional with a proven track record of hands-on success at drug development. And when hiring personnel to handle drug development, don't be seduced into choosing the least expensive. Choose as though you are seeking a surgeon to do your cardiac bypass surgery; because in drug development, as in cardiac surgery, there isn't much room for error."

In other words, don't give your money over to serial-losers like Seymour and Diwan, who have no knowledge, experience, or training remotely related to drug development, to develop drugs.